Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Harvard Business School
Cerilliant
Cipla
Deloitte
Boehringer Ingelheim
Chubb
Colorcon

Generated: May 24, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: travoprost

« Back to Dashboard

travoprost Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Mylan Pharms Inc travoprost 205050 0.004% SOLUTION;OPHTHALMIC
Par Pharm travoprost 091341 0.004% SOLUTION; OPHTHALMIC
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Covington
Accenture
Chinese Patent Office
US Army
Federal Trade Commission
Cerilliant
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.